Revotek Co. Ltd.

Revotek Co. Ltd. Introduction page to REVOTEK, an innovation-driven and science-lead Biotech company which pushes the boundaries of 3D Bioprinting.

Breaking! Following our years-long preclinical studies (and success) on the stem cell 3D bioprinted blood vessel (REVOVA...
28/01/2022

Breaking! Following our years-long preclinical studies (and success) on the stem cell 3D bioprinted blood vessel (REVOVAS) in animal models, we finally got APPROVAL from the National Health Commission of China to initiate the FIRST clinical trial on humans for peripheral artery diseases this year, 2022!

This is a huge breakthrough not just for our company but for the whole stem cell industry-REVOVAS is the first-ever clinical grade stem cell product constructed by 3D bioprinting, matures in vivo, and further drives the whole piece of tissue/organ regenerations successful.

Let's now look forward to the forthcoming event!



https://www.youtube.com/watch?v=fTzc51As7nE
23/04/2020

https://www.youtube.com/watch?v=fTzc51As7nE

This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by James Kang during the Augmented Virtual Reality and Other Cool...

Address

Dikang Avenue
Chengdu
610000

Alerts

Be the first to know and let us send you an email when Revotek Co. Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share